FULL PLATELET DEGRANULATION OCCURS IN RESPONSE TO PHYSIOLOGICAL AGONISTS IN THE PRESENCE OF GPIIB-IIIA ANTAGONISTS

被引:0
|
作者
WILSON, DJ [1 ]
COX, AD [1 ]
CHRONOS, NAF [1 ]
JANES, SL [1 ]
GOODALL, AH [1 ]
机构
[1] ROYAL FREE HOSP,SCH MED,ACAD DEPT HAEMATOL,HAEMOSTASIS UNIT,LONDON,ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:919 / 919
页数:1
相关论文
共 50 条
  • [31] Combined effects of GPIIb-IIIa antagonists, aspirin, apyrase and cytoskeletal inhibitors on preformed platelet aggregates.
    Frelinger, AL
    Mascelli, MA
    Jordan, R
    Marchese, PJ
    Barnard, MR
    Krueger, LA
    Furman, MI
    Michelson, AD
    BLOOD, 2002, 100 (11) : 256A - 256A
  • [32] Role of GPIb and GPIIb-IIIa as receptors for VWF in platelet-platelet interaction
    Wu, YP
    Ijsseldijk, MJW
    Schiphorst, ME
    Vink, T
    deGroot, PG
    Sixma, JJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 666 - 666
  • [33] EFFICIENT SURFACE EXPRESSION OF PLATELET GPIIB-IIIA REQUIRES BOTH SUBUNITS
    OTOOLE, TE
    LOFTUS, JC
    PLOW, EF
    GLASS, AA
    HARPER, JR
    GINSBERG, MH
    BLOOD, 1989, 74 (01) : 14 - 18
  • [34] THE ACTIVATION STATE OF THE PLATELET FIBRINOGEN RECEPTOR IS AN INTRINSIC PROPERTY OF GPIIB-IIIA
    OTOOLE, TE
    DU, XP
    RUGGERI, Z
    SHATTIL, S
    PLOW, EF
    GINSBURG, MH
    ARTERIOSCLEROSIS, 1990, 10 (05): : A897 - A897
  • [35] INTERACTION OF A GPIIB-IIIA DERIVED PEPTIDE WITH CALCIUM AND WITH PLATELET BINDING PEPTIDES
    BLUMENSTEIN, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 229 - 229
  • [36] THE CYTOPLASMIC DOMAIN OF PLATELET GPIIIA IS IMPORTANT FOR ACTIVATION OF THE GPIIB-IIIA COMPLEX
    FURIHATA, K
    HIDAKA, E
    UENO, I
    KATSUYAMA, T
    BLOOD, 1993, 82 (10) : A75 - A75
  • [37] Effect of mutagenesis of GPIIb amino acid 273 on the expression and conformation of the platelet integrin GPIIb-IIIa
    Kahn, MJ
    KieberEmmons, T
    Vilaire, G
    Murali, R
    Poncz, M
    Bennett, JS
    BIOCHEMISTRY, 1996, 35 (45) : 14304 - 14311
  • [38] NEW ANTIPLATELET AGENTS - PLATELET GPIIB/IIIA ANTAGONISTS
    COLLER, BS
    ANDERSON, K
    WEISMAN, HF
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (01) : 302 - 308
  • [39] Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa antagonists
    Schrör, K
    HERZ, 2001, 26 : 30 - 35
  • [40] Augmentation of platelet activation in the presence of GPIIb-IIIa antagonists can result from antibody-mediated FcγRIIa receptor activation.
    Krueger, LA
    Furman, MI
    Barnard, MR
    Frelinger, AL
    Michelson, AD
    BLOOD, 2002, 100 (11) : 62B - 62B